Adagio Medical Holdings, Inc.ADGMNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
40.74%
↑ 1001% above average
Average (11q)
3.70%
Historical baseline
Range
High:95.55%
Low:-59.85%
Volatility
4200.3%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 40.74% |
| Q2 2025 | -46.13% |
| Q1 2025 | 7.08% |
| Q4 2024 | 38.45% |
| Q3 2024 | -13.86% |
| Q2 2024 | -17.41% |
| Q1 2024 | 95.55% |
| Q4 2023 | -59.85% |
| Q3 2023 | 0.20% |
| Q2 2023 | -8.11% |
| Q1 2023 | 7.72% |
| Q4 2022 | 0.00% |